COSSU, MARIA VITTORIA
 Distribuzione geografica
Continente #
NA - Nord America 794
EU - Europa 613
AS - Asia 261
SA - Sud America 30
AF - Africa 24
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1733
Nazione #
US - Stati Uniti d'America 742
GB - Regno Unito 256
CN - Cina 147
IT - Italia 133
SE - Svezia 58
CA - Canada 46
ES - Italia 27
JP - Giappone 26
IN - India 24
DE - Germania 23
DK - Danimarca 20
FR - Francia 20
CH - Svizzera 17
NL - Olanda 15
TR - Turchia 15
VN - Vietnam 14
BR - Brasile 13
AR - Argentina 11
KR - Corea 11
AU - Australia 8
BE - Belgio 8
HK - Hong Kong 8
UA - Ucraina 7
ET - Etiopia 6
RU - Federazione Russa 6
BW - Botswana 5
FI - Finlandia 5
MX - Messico 5
TW - Taiwan 5
ZA - Sudafrica 5
CL - Cile 4
GR - Grecia 4
IE - Irlanda 4
RO - Romania 4
IR - Iran 3
UG - Uganda 3
CO - Colombia 2
KE - Kenya 2
LB - Libano 2
MW - Malawi 2
NZ - Nuova Zelanda 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
EE - Estonia 1
EU - Europa 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
Totale 1733
Città #
Southend 195
Houston 100
Fairfield 83
Redwood City 53
Milan 52
Seattle 51
Ashburn 43
Woodbridge 43
Chandler 41
Princeton 40
Ann Arbor 39
Wilmington 38
Toronto 34
Beijing 29
Cambridge 28
Nanjing 25
Dearborn 16
Des Moines 14
Shanghai 14
Dong Ket 13
Duncan 9
Nihon'odori 9
Fremont 8
Istanbul 8
Munro 8
Shenyang 8
San Diego 7
Jinan 6
Ottawa 6
Seoul 6
Central District 5
Gaborone 5
London 5
Los Angeles 5
Phoenix 5
Wenzhou 5
Bartlesville 4
Berlin 4
Brussels 4
Glenwood 4
Guangzhou 4
Haikou 4
Heusenstamm 4
Molina de Segura 4
Mumbai 4
Nanchang 4
Nora 4
Rome 4
Silver Spring 4
Taipei 4
Talamanca de Jarama 4
Wageningen 4
Zurich 4
Athens 3
Augusta 3
Buenos Aires 3
Changsha 3
Copenhagen 3
Kunming 3
Tijuana 3
Washington 3
Waverly 3
Zhengzhou 3
Barcelona 2
Bellevue 2
Brasília 2
Glasgow 2
Halifax 2
Hangzhou 2
Hebei 2
Jiaxing 2
Kawasaki 2
Las Vegas 2
Lausanne 2
Madrid 2
Magenta 2
Mesquite 2
Mexico 2
Montréal 2
Mountain View 2
Napoli 2
New Haven 2
New York 2
Ningbo 2
Norwalk 2
Nottingham 2
O'halloran Hill 2
Padova 2
Paris 2
Pierrefeu-du-var 2
Pittsburgh 2
Raleigh 2
Rho 2
Rotterdam 2
San Francisco 2
Santiago 2
Shenzhen 2
Sydney 2
Taiyuan 2
Tokyo 2
Totale 1228
Nome #
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients 509
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients 134
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 129
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48weeks' observational data 120
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 105
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 96
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents 94
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 87
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 87
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 81
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort 70
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 69
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 62
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 55
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data 49
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 28
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 28
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 26
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 22
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 13
Totale 1864
Categoria #
all - tutte 2347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201862 0751 57 614 4184
2018/2019161 25121111 38 153 10132228
2019/2020541 2491234 32142 6141 55574628
2020/2021477 47271728 3376 5643 39413139
2021/2022464 48273027 2838 3922 69401878
2022/2023103 574600 00 00 0000
Totale 1864